Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health

In‐host modeling of dengue virus and non‐structural protein 1 and the effects of ivermectin in patients with acute dengue fever

Ding J. et al, (2024), CPT: Pharmacometrics & Systems Pharmacology, 13, 2196 - 2209

Evidence that remdesivir treatment reduces viral titers in patients with COVID-19.

Boyd S. et al, (2024), Antimicrobial agents and chemotherapy

Monoclonal Antibodies to Treat Diphtheria.

White NJ., (2024), The Journal of infectious diseases

Artemisinin-resistant malaria.

White NJ. and Chotivanich K., (2024), Clin Microbiol Rev

Author Correction: Ivermectin metabolites reduce Anopheles survival.

Kobylinski KC. et al, (2024), Scientific reports, 14

Rectal artesunate: lives not saved

White NJ. et al, (2024), Transactions of The Royal Society of Tropical Medicine and Hygiene, 118, 639 - 641

Artemisinin-resistant malaria in Africa demands urgent action

Dhorda M. et al, (2024), Science, 385, 252 - 254

Load More